Company intelligence / Profile preview

NovoPath

Princeton, New Jersey, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

NovoPath is a leading provider of cloud-based Laboratory Information Systems (LIS) designed to streamline workflows for pathology laboratories. The company's flagship platform, NovoPath 360, offers comprehensive tools for anatomical, clinical, and molecular pathology, enabling labs to automate processes from specimen accessioning to final reporting. By integrating with diagnostic instruments and electronic health records, the software helps improve turnaround times and diagnostic precision. NovoPath serves a diverse client base, including hospital-based labs, independent diagnostic centers, and specialized pathology practices.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on NovoPath.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NovoPath.

Explore the full profile